Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2011

Open Access 01-12-2011 | Review

Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria

Author: Judith Miklossy

Published in: Journal of Neuroinflammation | Issue 1/2011

Login to get access

Abstract

It is established that chronic spirochetal infection can cause slowly progressive dementia, brain atrophy and amyloid deposition in late neurosyphilis. Recently it has been suggested that various types of spirochetes, in an analogous way to Treponema pallidum, could cause dementia and may be involved in the pathogenesis of Alzheimer's disease (AD). Here, we review all data available in the literature on the detection of spirochetes in AD and critically analyze the association and causal relationship between spirochetes and AD following established criteria of Koch and Hill. The results show a statistically significant association between spirochetes and AD (P = 1.5 × 10-17, OR = 20, 95% CI = 8-60, N = 247). When neutral techniques recognizing all types of spirochetes were used, or the highly prevalent periodontal pathogen Treponemas were analyzed, spirochetes were observed in the brain in more than 90% of AD cases. Borrelia burgdorferi was detected in the brain in 25.3% of AD cases analyzed and was 13 times more frequent in AD compared to controls. Periodontal pathogen Treponemas (T. pectinovorum, T. amylovorum, T. lecithinolyticum, T. maltophilum, T. medium, T. socranskii) and Borrelia burgdorferi were detected using species specific PCR and antibodies. Importantly, co-infection with several spirochetes occurs in AD. The pathological and biological hallmarks of AD were reproduced in vitro by exposure of mammalian cells to spirochetes. The analysis of reviewed data following Koch's and Hill's postulates shows a probable causal relationship between neurospirochetosis and AD. Persisting inflammation and amyloid deposition initiated and sustained by chronic spirochetal infection form together with the various hypotheses suggested to play a role in the pathogenesis of AD a comprehensive entity. As suggested by Hill, once the probability of a causal relationship is established prompt action is needed. Support and attention should be given to this field of AD research. Spirochetal infection occurs years or decades before the manifestation of dementia. As adequate antibiotic and anti-inflammatory therapies are available, as in syphilis, one might prevent and eradicate dementia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984, 1: 1311-1315.PubMed Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984, 1: 1311-1315.PubMed
2.
go back to reference Laitinen K, Laurila A, Pyhälä L, Leinonen M, Saikku P: Chlamydia pneumonia infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997, 65: 4832-4835.PubMedCentralPubMed Laitinen K, Laurila A, Pyhälä L, Leinonen M, Saikku P: Chlamydia pneumonia infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997, 65: 4832-4835.PubMedCentralPubMed
3.
go back to reference Saikku P: Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J. 1999, S138: 500-503. Saikku P: Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J. 1999, S138: 500-503.
4.
go back to reference Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994, 71: 437-439. 10.1136/hrt.71.5.437.PubMedCentralPubMed Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994, 71: 437-439. 10.1136/hrt.71.5.437.PubMedCentralPubMed
5.
go back to reference Martîn-de-Argila C, Boixeda D, Cantón R, Gisbert JP, Fuertes A: High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet. 1995, 346: 310.PubMed Martîn-de-Argila C, Boixeda D, Cantón R, Gisbert JP, Fuertes A: High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet. 1995, 346: 310.PubMed
6.
go back to reference Renvert S, Pettersson T, Ohlsson O, Persson GR: Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. J Periodontol. 2006, 77: 1110-1119. 10.1902/jop.2006.050336.PubMed Renvert S, Pettersson T, Ohlsson O, Persson GR: Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. J Periodontol. 2006, 77: 1110-1119. 10.1902/jop.2006.050336.PubMed
7.
go back to reference Zaremba M, Górska R, Suwalski P, Kowalski J: Evaluation of the Incidence of Periodontitis-Associated Bacteria in the Atherosclerotic Plaque of Coronary Blood Vessels. J Periodontol. 2007, 78: 322-327. 10.1902/jop.2006.060081.PubMed Zaremba M, Górska R, Suwalski P, Kowalski J: Evaluation of the Incidence of Periodontitis-Associated Bacteria in the Atherosclerotic Plaque of Coronary Blood Vessels. J Periodontol. 2007, 78: 322-327. 10.1902/jop.2006.060081.PubMed
8.
go back to reference Chiu B: Multiple infections in carotid atherosclerotic plaques. Am Heart J. 1999, 138: S534-536. 10.1016/S0002-8703(99)70294-2.PubMed Chiu B: Multiple infections in carotid atherosclerotic plaques. Am Heart J. 1999, 138: S534-536. 10.1016/S0002-8703(99)70294-2.PubMed
9.
go back to reference Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ: Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000, 71: 1554-1560. 10.1902/jop.2000.71.10.1554.PubMed Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ: Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000, 71: 1554-1560. 10.1902/jop.2000.71.10.1554.PubMed
10.
go back to reference Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E: Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis. 2001, 158: 73-79. 10.1016/S0021-9150(01)00411-7.PubMed Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E: Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis. 2001, 158: 73-79. 10.1016/S0021-9150(01)00411-7.PubMed
11.
go back to reference Toplak H, Haller EM, Lauermann T, Weber K, Bahadori B, Reisinger EC, Tilz GP, Wascher TC: Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients. Diabetes Res Clin Pract. 1996, 32: 97-101. 10.1016/0168-8227(96)01216-8.PubMed Toplak H, Haller EM, Lauermann T, Weber K, Bahadori B, Reisinger EC, Tilz GP, Wascher TC: Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients. Diabetes Res Clin Pract. 1996, 32: 97-101. 10.1016/0168-8227(96)01216-8.PubMed
12.
go back to reference Kozák R, Juhász E, Horvát G, Harcsa E, Lövei L, Sike R, Szele K: Helicobacter pylori infection in diabetic patients. Orv Hetil. 1999, 140: 993-995.PubMed Kozák R, Juhász E, Horvát G, Harcsa E, Lövei L, Sike R, Szele K: Helicobacter pylori infection in diabetic patients. Orv Hetil. 1999, 140: 993-995.PubMed
13.
go back to reference Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT: Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol. 2001, 32: 215-217. 10.1097/00004836-200103000-00006.PubMed Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT: Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol. 2001, 32: 215-217. 10.1097/00004836-200103000-00006.PubMed
14.
go back to reference Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y: Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest. 2005, 28: 214-217.PubMed Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y: Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest. 2005, 28: 214-217.PubMed
15.
go back to reference Hughes MK, Fusillo MH, Roberson BS: Positive fluorescent treponemal antibody reactions in diabetes. Appl Microbiol. 1970, 19: 425-428.PubMedCentralPubMed Hughes MK, Fusillo MH, Roberson BS: Positive fluorescent treponemal antibody reactions in diabetes. Appl Microbiol. 1970, 19: 425-428.PubMedCentralPubMed
16.
go back to reference Miklossy J, Martins RN, Darbinian N, Khalili K, McGeer PL: Type 2 Diabetes: Local Inflammation and Direct Effect of Bacterial Toxic Components. Open Pathol J. 2006, 2: 86-95. Miklossy J, Martins RN, Darbinian N, Khalili K, McGeer PL: Type 2 Diabetes: Local Inflammation and Direct Effect of Bacterial Toxic Components. Open Pathol J. 2006, 2: 86-95.
17.
go back to reference Martin RJ: Infections and asthma. Clin Chest Med. 2006, 27: 87-98. 10.1016/j.ccm.2005.10.004.PubMed Martin RJ: Infections and asthma. Clin Chest Med. 2006, 27: 87-98. 10.1016/j.ccm.2005.10.004.PubMed
18.
go back to reference MacDowell AL, Bacharier LB: Infectious triggers of asthma. Immunol Allergy Clin North Am. 2005, 25: 45-66. 10.1016/j.iac.2004.09.011.PubMed MacDowell AL, Bacharier LB: Infectious triggers of asthma. Immunol Allergy Clin North Am. 2005, 25: 45-66. 10.1016/j.iac.2004.09.011.PubMed
19.
go back to reference Micillo E, Bianco A, D'Auria D, Mazzarella G, Abbate GF: Respiratory infections and asthma. Allergy. 2000, Suppl 61: 42-45. Micillo E, Bianco A, D'Auria D, Mazzarella G, Abbate GF: Respiratory infections and asthma. Allergy. 2000, Suppl 61: 42-45.
20.
go back to reference Teig N, Anders A, Schmidt C, Rieger C, Gatermann S: Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax. 2005, 60: 962-966. 10.1136/thx.2005.041004.PubMedCentralPubMed Teig N, Anders A, Schmidt C, Rieger C, Gatermann S: Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax. 2005, 60: 962-966. 10.1136/thx.2005.041004.PubMedCentralPubMed
21.
go back to reference Goldman CG, Mitchell HM: Helicobacter spp. other than Helicobacter pylori. Helicobacter. 2010, 15 (Suppl 1): 69-75.PubMed Goldman CG, Mitchell HM: Helicobacter spp. other than Helicobacter pylori. Helicobacter. 2010, 15 (Suppl 1): 69-75.PubMed
22.
go back to reference Vermeire S, Van Assche G, Rutgeerts P: Inflammatory bowel disease and colitis? new concepts from the bench and the clinic. Curr Opin Gastroenterol. 2011, 27: 32-37. 10.1097/MOG.0b013e3283412e87.PubMed Vermeire S, Van Assche G, Rutgeerts P: Inflammatory bowel disease and colitis? new concepts from the bench and the clinic. Curr Opin Gastroenterol. 2011, 27: 32-37. 10.1097/MOG.0b013e3283412e87.PubMed
23.
go back to reference Navaneethan U, Giannella RA: Infectious colitis. Curr Opin Gastroenterol,. 2011, 27: 66-71. 10.1097/MOG.0b013e3283400755. Navaneethan U, Giannella RA: Infectious colitis. Curr Opin Gastroenterol,. 2011, 27: 66-71. 10.1097/MOG.0b013e3283400755.
24.
go back to reference Hasan N, Pollack A, Cho I: Infectious causes of colorectal cancer. Infect Dis Clin North Am. 2010, 4: 1019-1039. Hasan N, Pollack A, Cho I: Infectious causes of colorectal cancer. Infect Dis Clin North Am. 2010, 4: 1019-1039.
25.
go back to reference Lalande JD, Behr MA: Mycobacteria in Crohn's disease: how innate immune deficiency may result in chronic inflammation. Expert Rev Clin Immunol. 2010, 6: 633-641. 10.1586/eci.10.29.PubMed Lalande JD, Behr MA: Mycobacteria in Crohn's disease: how innate immune deficiency may result in chronic inflammation. Expert Rev Clin Immunol. 2010, 6: 633-641. 10.1586/eci.10.29.PubMed
26.
go back to reference Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK: Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol. 1977, 15: 25-33. 10.1159/000114785.PubMed Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK: Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol. 1977, 15: 25-33. 10.1159/000114785.PubMed
27.
go back to reference Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H: Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science. 1985, 228: 755-756. 10.1126/science.3922055.PubMed Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H: Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science. 1985, 228: 755-756. 10.1126/science.3922055.PubMed
28.
go back to reference Beaman BL: Bacteria and neurodegeneration. Neurodegenerative Diseases. Edited by: Caino DWB, Saunders, Orlando, FL. 1994, 319-338. Beaman BL: Bacteria and neurodegeneration. Neurodegenerative Diseases. Edited by: Caino DWB, Saunders, Orlando, FL. 1994, 319-338.
29.
go back to reference Miklossy J: Biology and neuropathology of dementia in syphilis and Lyme disease. Dementias. Edited by: Duyckaerts C, Litvan I. 2008, Edinburgh, London, New York, Oxford, Philadelphia, St-Louis, Toronto, Sydney: Elsevier, 825-844. Series Editor Aminoff MJ, Boller F, Schwab DS: Handbook of Clinical Neurology vol. 89 Miklossy J: Biology and neuropathology of dementia in syphilis and Lyme disease. Dementias. Edited by: Duyckaerts C, Litvan I. 2008, Edinburgh, London, New York, Oxford, Philadelphia, St-Louis, Toronto, Sydney: Elsevier, 825-844. Series Editor Aminoff MJ, Boller F, Schwab DS: Handbook of Clinical Neurology vol. 89
30.
go back to reference Salvatore M, Morzunov S, Schwemmle M, Lipkin WI: Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Lancet. 1997, 349: 1813-1814. 10.1016/S0140-6736(05)61693-5.PubMed Salvatore M, Morzunov S, Schwemmle M, Lipkin WI: Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Lancet. 1997, 349: 1813-1814. 10.1016/S0140-6736(05)61693-5.PubMed
31.
go back to reference Langford D, Masliah E: The emerging role of infectious pathogens in neurodegenerative diseases. Exp Neurol. 2003, 184: 553-555. 10.1016/S0014-4886(03)00365-0.PubMed Langford D, Masliah E: The emerging role of infectious pathogens in neurodegenerative diseases. Exp Neurol. 2003, 184: 553-555. 10.1016/S0014-4886(03)00365-0.PubMed
32.
go back to reference Fischer O: Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatschr f Psychiat Neurol. 1907, 22: 361-372. 10.1159/000211873. Fischer O: Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatschr f Psychiat Neurol. 1907, 22: 361-372. 10.1159/000211873.
33.
go back to reference Alzheimer A: Über eigenartige Krankheitsfälle des späteren Alters. Z Ges Neurol Psychiat. 1911, 4: 356-385. 10.1007/BF02866241. Alzheimer A: Über eigenartige Krankheitsfälle des späteren Alters. Z Ges Neurol Psychiat. 1911, 4: 356-385. 10.1007/BF02866241.
34.
go back to reference Koch R: Die Aetiologie der Tuberculose. Mitt Kaiser Gesundh. 1884, 2: 1-88. Koch R: Die Aetiologie der Tuberculose. Mitt Kaiser Gesundh. 1884, 2: 1-88.
35.
go back to reference Koch R: Ueber den augenblicklichen Stand der bakteriologischen Cholera Diagnose. J Hyg Inf. 1893, 14: 319-333. 10.1007/BF02284324. Koch R: Ueber den augenblicklichen Stand der bakteriologischen Cholera Diagnose. J Hyg Inf. 1893, 14: 319-333. 10.1007/BF02284324.
36.
go back to reference Hill AB: The environment and disease: Association or causation?. Proceedings of the Royal Society of Medicine, Section of Occupational Medicine, Meeting January. 1965, 14: 295-300. Hill AB: The environment and disease: Association or causation?. Proceedings of the Royal Society of Medicine, Section of Occupational Medicine, Meeting January. 1965, 14: 295-300.
37.
go back to reference Alzheimer A: Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Med. 1907, 64: 146-148. Alzheimer A: Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Med. 1907, 64: 146-148.
38.
go back to reference Katzman R: The prevalence and malignancy of Alzheimer's disease: a major killer. Arch Neurol. 1976, 33: 217-218.PubMed Katzman R: The prevalence and malignancy of Alzheimer's disease: a major killer. Arch Neurol. 1976, 33: 217-218.PubMed
39.
go back to reference Terry RD, Davies P: Dementia of the Alzheimer type. Ann Rev Neurosci. 1980, 3: 77-95. 10.1146/annurev.ne.03.030180.000453.PubMed Terry RD, Davies P: Dementia of the Alzheimer type. Ann Rev Neurosci. 1980, 3: 77-95. 10.1146/annurev.ne.03.030180.000453.PubMed
40.
go back to reference Bertram L, Tanzi RE: The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005, 115: 1449-1457. 10.1172/JCI24761.PubMedCentralPubMed Bertram L, Tanzi RE: The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005, 115: 1449-1457. 10.1172/JCI24761.PubMedCentralPubMed
41.
go back to reference Nagy Z: The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. J Cell Mol Med. 2005, 9: 531-541. 10.1111/j.1582-4934.2005.tb00485.x.PubMed Nagy Z: The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. J Cell Mol Med. 2005, 9: 531-541. 10.1111/j.1582-4934.2005.tb00485.x.PubMed
42.
go back to reference Tanzi RE, Vaula G, Romano DM, Mortilla M, Huang TL, Tupler RG, Wasco W, Hyman BT, Haines JL, Jenkins BJ, et al: Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet. 1992, 51: 273-282.PubMedCentralPubMed Tanzi RE, Vaula G, Romano DM, Mortilla M, Huang TL, Tupler RG, Wasco W, Hyman BT, Haines JL, Jenkins BJ, et al: Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet. 1992, 51: 273-282.PubMedCentralPubMed
43.
go back to reference Roses AD: Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease. Neurobiol Aging. 1994, 2 (Suppl): 165-167. Roses AD: Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease. Neurobiol Aging. 1994, 2 (Suppl): 165-167.
44.
go back to reference McGeer PL, McGeer EG: Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol. 2001, 58: 1790-1792. 10.1001/archneur.58.11.1790.PubMed McGeer PL, McGeer EG: Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol. 2001, 58: 1790-1792. 10.1001/archneur.58.11.1790.PubMed
45.
go back to reference Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007, 39: 17-23. 10.1038/ng1934.PubMed Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007, 39: 17-23. 10.1038/ng1934.PubMed
46.
go back to reference Guo JP, Arai T, Miklossy J, McGeer PL: Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer disease. Proc Natl Acad Sci USA. 2006, 103: 1953-1938. 10.1073/pnas.0509386103.PubMedCentralPubMed Guo JP, Arai T, Miklossy J, McGeer PL: Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer disease. Proc Natl Acad Sci USA. 2006, 103: 1953-1938. 10.1073/pnas.0509386103.PubMedCentralPubMed
47.
go back to reference Perry G, Richey PL, Siedlak SL, Smith MA, Mulvihill P, DeWitt DA, Barnett J, Greenberg BD, Kalaria RN: Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol. 1993, 143: 1586-1593.PubMedCentralPubMed Perry G, Richey PL, Siedlak SL, Smith MA, Mulvihill P, DeWitt DA, Barnett J, Greenberg BD, Kalaria RN: Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol. 1993, 143: 1586-1593.PubMedCentralPubMed
48.
go back to reference McGeer PL, Itagaki S, Tago H, McGeer EG: Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett. 1987, 79: 195-200. 10.1016/0304-3940(87)90696-3.PubMed McGeer PL, Itagaki S, Tago H, McGeer EG: Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett. 1987, 79: 195-200. 10.1016/0304-3940(87)90696-3.PubMed
49.
go back to reference Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 1989, 86: 7611-7615. 10.1073/pnas.86.19.7611.PubMedCentralPubMed Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 1989, 86: 7611-7615. 10.1073/pnas.86.19.7611.PubMedCentralPubMed
50.
go back to reference McGeer PL, Rogers J: Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 1992, 42: 447-449.PubMed McGeer PL, Rogers J: Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 1992, 42: 447-449.PubMed
51.
go back to reference Schwab C, McGeer PL: Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis. 2008, 13: 359-369.PubMed Schwab C, McGeer PL: Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis. 2008, 13: 359-369.PubMed
52.
go back to reference McGeer PL, McGeer EG: The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev. 1995, 21: 195-218. 10.1016/0165-0173(95)00011-9.PubMed McGeer PL, McGeer EG: The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev. 1995, 21: 195-218. 10.1016/0165-0173(95)00011-9.PubMed
53.
go back to reference McGeer PL, McGeer EG: Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol. 2002, 8: 529-538. 10.1080/13550280290100969.PubMed McGeer PL, McGeer EG: Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol. 2002, 8: 529-538. 10.1080/13550280290100969.PubMed
54.
go back to reference Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J: Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging. 1997, 18: 415-421. 10.1016/S0197-4580(97)00042-0.PubMed Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J: Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging. 1997, 18: 415-421. 10.1016/S0197-4580(97)00042-0.PubMed
55.
go back to reference Stewart WF, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997, 48: 626-632.PubMed Stewart WF, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997, 48: 626-632.PubMed
56.
go back to reference Anthony JC, Breitner JC, Zandi PP, Meyer MR, Jurasova I, Norton MC, Stone SV: Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study. Neurology. 2000, 59: 880-886. Anthony JC, Breitner JC, Zandi PP, Meyer MR, Jurasova I, Norton MC, Stone SV: Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study. Neurology. 2000, 59: 880-886.
57.
go back to reference in't Veld BA, Launer LJ, Hoes AW, Ott A, Hofman A, Breteler MM, Stricker BH: NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging. 1998, 19: 607-611. 10.1016/S0197-4580(98)00096-7. in't Veld BA, Launer LJ, Hoes AW, Ott A, Hofman A, Breteler MM, Stricker BH: NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging. 1998, 19: 607-611. 10.1016/S0197-4580(98)00096-7.
58.
go back to reference Hübner AH: Zur Histopathologie der senilen Hirnrinde. Arch Psychiat Neurol. 1908, 46: 598-609. Hübner AH: Zur Histopathologie der senilen Hirnrinde. Arch Psychiat Neurol. 1908, 46: 598-609.
59.
go back to reference Perusini G: Histology and clinical findings of some psychiatric diseases of older people. (Perusini G. Histologische und hispopathologische Arbeiten. Edited by: Nissl F, Alzheimer A. 1910, Gustav Fischer, Jena, 3: 297-351. In The early story of Alzheimer's disease. Translation of the historic papers by Alois Alzheimer, Oskar Fischer, Francesco Bonfiglio, Emil Kraepelin, Gaetano Perusini. Edited by Bick K, Amaducci L, Pepeu G. Padova, Liviana press: 1987: 82-128. Perusini G: Histology and clinical findings of some psychiatric diseases of older people. (Perusini G. Histologische und hispopathologische Arbeiten. Edited by: Nissl F, Alzheimer A. 1910, Gustav Fischer, Jena, 3: 297-351. In The early story of Alzheimer's disease. Translation of the historic papers by Alois Alzheimer, Oskar Fischer, Francesco Bonfiglio, Emil Kraepelin, Gaetano Perusini. Edited by Bick K, Amaducci L, Pepeu G. Padova, Liviana press: 1987: 82-128.
60.
go back to reference Noguchi H, Moore JW: A demonstration of Treponema pallidum in the brain of general paralysis cases. J Exp Med. 1913, 17: 232-238. 10.1084/jem.17.2.232.PubMedCentralPubMed Noguchi H, Moore JW: A demonstration of Treponema pallidum in the brain of general paralysis cases. J Exp Med. 1913, 17: 232-238. 10.1084/jem.17.2.232.PubMedCentralPubMed
61.
go back to reference Pacheco e Silva AC: Espirochetose dos centros nervos. Memorias do hospicio de Juquery, anno III-IV. 1926, 3-4: 1-27. Pacheco e Silva AC: Espirochetose dos centros nervos. Memorias do hospicio de Juquery, anno III-IV. 1926, 3-4: 1-27.
62.
go back to reference Pacheco e Silva AC: Localisation du Treponema Pallidum dans le cerveau des paralytiques généraux. Rev Neurol. 1926, 2: 558-565. Pacheco e Silva AC: Localisation du Treponema Pallidum dans le cerveau des paralytiques généraux. Rev Neurol. 1926, 2: 558-565.
63.
go back to reference Merritt HH, Adams RD, Solomon HC: Neurosyphilis. 1946, Oxford University Press, London Merritt HH, Adams RD, Solomon HC: Neurosyphilis. 1946, Oxford University Press, London
64.
go back to reference Bonfiglio F: Di speciali reperti in un caso di probabile sifilide cerebrale. Riv Speriment Fren. 1908, 34: 196-206. Bonfiglio F: Di speciali reperti in un caso di probabile sifilide cerebrale. Riv Speriment Fren. 1908, 34: 196-206.
65.
go back to reference Vinken PJ, Bruyn GW: Handbook of Neurology. 1978, Amsterdam, New York: Elsevier, 33. Vinken PJ, Bruyn GW: Handbook of Neurology. 1978, Amsterdam, New York: Elsevier, 33.
66.
go back to reference Volland W: Die Kolloide Degeneration des Gehirns bei progressiver Paralyse in ihrer Beziehung zur lokalen Amyloidose. Dtsch Path Gesellsch. 1938, 31: 515-520. Volland W: Die Kolloide Degeneration des Gehirns bei progressiver Paralyse in ihrer Beziehung zur lokalen Amyloidose. Dtsch Path Gesellsch. 1938, 31: 515-520.
67.
go back to reference Miklossy J, Rosemberg S, McGeer PL: Beta amyloid deposition in the atrophic form of general paresis. Alzheimer's Disease: New advances. Proceedings of the 10th International Congress on Alzheimer's Disease (ICAD). Edited by: Iqbal K, Winblad B, Avila J. 2006, Medimond, International Proceedings, 429-433. Miklossy J, Rosemberg S, McGeer PL: Beta amyloid deposition in the atrophic form of general paresis. Alzheimer's Disease: New advances. Proceedings of the 10th International Congress on Alzheimer's Disease (ICAD). Edited by: Iqbal K, Winblad B, Avila J. 2006, Medimond, International Proceedings, 429-433.
68.
go back to reference MacDonald AB: Borrelia in the brains of patients dying with dementia. JAMA. 1986, 256: 2195-2196.PubMed MacDonald AB: Borrelia in the brains of patients dying with dementia. JAMA. 1986, 256: 2195-2196.PubMed
69.
go back to reference Dupuis MJ: Multiple neurologic manifestations of Borrelia burgdorferi infection. Rev Neurol. 1988, 144: 765-775.PubMed Dupuis MJ: Multiple neurologic manifestations of Borrelia burgdorferi infection. Rev Neurol. 1988, 144: 765-775.PubMed
70.
go back to reference Miklossy J: Alzheimer's disease - A spirochetosis?. Neuroreport. 1993, 4: 841-848. 10.1097/00001756-199307000-00002.PubMed Miklossy J: Alzheimer's disease - A spirochetosis?. Neuroreport. 1993, 4: 841-848. 10.1097/00001756-199307000-00002.PubMed
71.
go back to reference Schaeffer S, Le Doze F, De la Sayette V, Bertran F, Viader F: Dementia in Lyme disease. Presse Med. 1994, 123: 861. Schaeffer S, Le Doze F, De la Sayette V, Bertran F, Viader F: Dementia in Lyme disease. Presse Med. 1994, 123: 861.
72.
go back to reference Fallon BA, Nields JA: Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994, 151: 1571-1583.PubMed Fallon BA, Nields JA: Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994, 151: 1571-1583.PubMed
73.
go back to reference Pennekamp A, Jaques M: Chronic neuroborreliosis with gait ataxia and cognitive disorders. Praxis. 1997, 86: 867-869.PubMed Pennekamp A, Jaques M: Chronic neuroborreliosis with gait ataxia and cognitive disorders. Praxis. 1997, 86: 867-869.PubMed
74.
go back to reference Southern P, Sanford J: Relapsing fever: a clinical and microbiological review. Medicine. 1969, 48: 129-149. Southern P, Sanford J: Relapsing fever: a clinical and microbiological review. Medicine. 1969, 48: 129-149.
75.
go back to reference Thein M, Bunikis I, Denker K, Larsson C, Cutler S, Drancourt M, Schwan TG, Mentele R, Lottspeich F, Bergström S, Benz R: : Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes. J Bacteriol. 2008, 190: 7035-7042. 10.1128/JB.00818-08.PubMedCentralPubMed Thein M, Bunikis I, Denker K, Larsson C, Cutler S, Drancourt M, Schwan TG, Mentele R, Lottspeich F, Bergström S, Benz R: : Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes. J Bacteriol. 2008, 190: 7035-7042. 10.1128/JB.00818-08.PubMedCentralPubMed
76.
go back to reference Paster BJ, Dewhirst FE: Phylogenetic foundation of spirochetes. J Mol Microbiol Biotechnol. 2000, 2: 341-344.PubMed Paster BJ, Dewhirst FE: Phylogenetic foundation of spirochetes. J Mol Microbiol Biotechnol. 2000, 2: 341-344.PubMed
77.
go back to reference Dewhirst FE, Tamer MA, Ericson RE, Lau CN, Levanos VA, Boches SK, Galvin JL, Paster BJ: The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol Immunol. 2000, 15: 196-202. 10.1034/j.1399-302x.2000.150308.x.PubMed Dewhirst FE, Tamer MA, Ericson RE, Lau CN, Levanos VA, Boches SK, Galvin JL, Paster BJ: The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol Immunol. 2000, 15: 196-202. 10.1034/j.1399-302x.2000.150308.x.PubMed
78.
go back to reference Mikosza AS, La T, de Boer WB, Hampson DJ: Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia. J Clin Microbiol. 2001, 39: 347-350. 10.1128/JCM.39.1.347-350.2001.PubMedCentralPubMed Mikosza AS, La T, de Boer WB, Hampson DJ: Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia. J Clin Microbiol. 2001, 39: 347-350. 10.1128/JCM.39.1.347-350.2001.PubMedCentralPubMed
79.
go back to reference Trott DJ, Jensen NS, Saint Girons I, Oxberry SL, Stanton TB, Lindquist D, Hampson DJ: Identification and characterization of Serpulina pilosicoli isolates recovered from the blood of critically ill patients. J Clin Microbiol. 1997, 35: 482-485.PubMedCentralPubMed Trott DJ, Jensen NS, Saint Girons I, Oxberry SL, Stanton TB, Lindquist D, Hampson DJ: Identification and characterization of Serpulina pilosicoli isolates recovered from the blood of critically ill patients. J Clin Microbiol. 1997, 35: 482-485.PubMedCentralPubMed
80.
go back to reference Miklossy J, Kasas S, Janzer RC, Ardizzoni F, Van der Loos H: Further morphological evidence for a spirochetal etiology of Alzheimer's Disease. NeuroReport. 1994, 5: 1201-1204.PubMed Miklossy J, Kasas S, Janzer RC, Ardizzoni F, Van der Loos H: Further morphological evidence for a spirochetal etiology of Alzheimer's Disease. NeuroReport. 1994, 5: 1201-1204.PubMed
81.
go back to reference Miklossy J: The spirochetal etiology of Alzheimer's disease: A putative therapeutic approach. Alzheimer Disease: Therapeutic Strategies. Proceedings of the Third International Springfield Alzheimer Symposium. Edited by: Giacobini E, Becker R. 1994, Birkhauser Boston Inc., 41-48. Part I Miklossy J: The spirochetal etiology of Alzheimer's disease: A putative therapeutic approach. Alzheimer Disease: Therapeutic Strategies. Proceedings of the Third International Springfield Alzheimer Symposium. Edited by: Giacobini E, Becker R. 1994, Birkhauser Boston Inc., 41-48. Part I
82.
go back to reference Miklossy J, Gern L, Darekar P, Janzer RC, Van der, Loos H: Senile plaques, neurofibrillary tangles and neuropil threads contain DNA?. J Spirochetal and Tick-borne Dis (JSTD). 1995, 2: 1-5. Miklossy J, Gern L, Darekar P, Janzer RC, Van der, Loos H: Senile plaques, neurofibrillary tangles and neuropil threads contain DNA?. J Spirochetal and Tick-borne Dis (JSTD). 1995, 2: 1-5.
83.
go back to reference Miklossy J, Darekar P, Gern L, Janzer RC, Bosman FT: Bacterial peptidoglycan in neuritic plaques in Alzheimer's disease. Azheimer's Res. 1996, 2: 95-100. Miklossy J, Darekar P, Gern L, Janzer RC, Bosman FT: Bacterial peptidoglycan in neuritic plaques in Alzheimer's disease. Azheimer's Res. 1996, 2: 95-100.
84.
go back to reference Miklossy J: Chronic inflammation and amyloidogenesis in Alzheimer's disease: Putative role of bacterial peptidoglycan, a potent inflammatory and amyloidogenic factor. Alzheimer's Rev. 1998, 3: 45-51. Miklossy J: Chronic inflammation and amyloidogenesis in Alzheimer's disease: Putative role of bacterial peptidoglycan, a potent inflammatory and amyloidogenic factor. Alzheimer's Rev. 1998, 3: 45-51.
85.
go back to reference Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ: Borrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimer's Dis. 2004, 6: 1-11. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ: Borrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimer's Dis. 2004, 6: 1-11.
86.
go back to reference Miklossy J: Chronic inflammation and amyloidogenesis in Alzheimer's disease - role of spirochetes. J Alzheimer's Dis. 2008, 13: 381-391. Miklossy J: Chronic inflammation and amyloidogenesis in Alzheimer's disease - role of spirochetes. J Alzheimer's Dis. 2008, 13: 381-391.
87.
go back to reference Hesse L, Bostock J, Dementin S, Blanot D, Mengin-Lecreulx D, Chopra I: Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity. J Bacteriol. 2003, 185: 6507-6512. 10.1128/JB.185.22.6507-6512.2003.PubMedCentralPubMed Hesse L, Bostock J, Dementin S, Blanot D, Mengin-Lecreulx D, Chopra I: Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity. J Bacteriol. 2003, 185: 6507-6512. 10.1128/JB.185.22.6507-6512.2003.PubMedCentralPubMed
88.
go back to reference McCoy AJ, Adams NE, Hudson AO, Gilvarg C, Leustek T, Maurelli AT: L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine. Proc Natl Acad Sci USA. 2006, 103: 17909-17914. 10.1073/pnas.0608643103.PubMedCentralPubMed McCoy AJ, Adams NE, Hudson AO, Gilvarg C, Leustek T, Maurelli AT: L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine. Proc Natl Acad Sci USA. 2006, 103: 17909-17914. 10.1073/pnas.0608643103.PubMedCentralPubMed
89.
go back to reference Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL: Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008, 5: 40-10.1186/1742-2094-5-40.PubMedCentralPubMed Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL: Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008, 5: 40-10.1186/1742-2094-5-40.PubMedCentralPubMed
90.
go back to reference McLaughlin R, Kin NM, Chen MF, Nair NP, Chan EC: Alzheimer's disease may not be a spirochetosis. Neuroreport. 1999, 10: 1489-1491. 10.1097/00001756-199905140-00018.PubMed McLaughlin R, Kin NM, Chen MF, Nair NP, Chan EC: Alzheimer's disease may not be a spirochetosis. Neuroreport. 1999, 10: 1489-1491. 10.1097/00001756-199905140-00018.PubMed
91.
go back to reference Gastinel P: Précis de bactériologie médicale. Collections de récis médicaux. 1949, Masson and Cie, Paris Gastinel P: Précis de bactériologie médicale. Collections de récis médicaux. 1949, Masson and Cie, Paris
92.
go back to reference Jacquet L, Sézary A: Des formes atypiques et dégénératives du tréponéme pâle. Bull mem Soc Med Hop Par. 1907, 24: 114. Jacquet L, Sézary A: Des formes atypiques et dégénératives du tréponéme pâle. Bull mem Soc Med Hop Par. 1907, 24: 114.
93.
go back to reference Mattman LH: Cell wall deficient forms: stealth pathogens. 1993, CRC Press, Inc, Boca Raton, Fla., 2 Mattman LH: Cell wall deficient forms: stealth pathogens. 1993, CRC Press, Inc, Boca Raton, Fla., 2
94.
go back to reference Chan EC, Klitorinos A, Gharbia S, Caudry SD, Rahal MD, Siboo R: Characterization of a 4.2-kb plasmid isolated from periodontopathic spirochetes. Oral Microbiol Immunol. 1996, 11: 365-368. 10.1111/j.1399-302X.1996.tb00196.x.PubMed Chan EC, Klitorinos A, Gharbia S, Caudry SD, Rahal MD, Siboo R: Characterization of a 4.2-kb plasmid isolated from periodontopathic spirochetes. Oral Microbiol Immunol. 1996, 11: 365-368. 10.1111/j.1399-302X.1996.tb00196.x.PubMed
95.
go back to reference Riviere GR, Weisz KS, Adams DF, Thomas DD: Pathogen-related oral spirochetes from dental plaque are invasive. Infect Immun. 1991, 59: 3377-3380.PubMedCentralPubMed Riviere GR, Weisz KS, Adams DF, Thomas DD: Pathogen-related oral spirochetes from dental plaque are invasive. Infect Immun. 1991, 59: 3377-3380.PubMedCentralPubMed
96.
go back to reference Riviere GR, Riviere KH, Smith KS: Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol. 2002, 17: 113-118. 10.1046/j.0902-0055.2001.00100.x.PubMed Riviere GR, Riviere KH, Smith KS: Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol. 2002, 17: 113-118. 10.1046/j.0902-0055.2001.00100.x.PubMed
97.
go back to reference Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ: Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alz Dis. 2008, 13: 437-449. Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ: Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alz Dis. 2008, 13: 437-449.
98.
go back to reference MacDonald AB, Miranda JM: Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol. 1987, 18: 759-761. 10.1016/S0046-8177(87)80252-6.PubMed MacDonald AB, Miranda JM: Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol. 1987, 18: 759-761. 10.1016/S0046-8177(87)80252-6.PubMed
99.
go back to reference MacDonald AB: Concurrent neocortical borreliosis and Alzheimer's Disease. Ann N Y Acad Sci. 1988, 539: 468-470. 10.1111/j.1749-6632.1988.tb31909.x. MacDonald AB: Concurrent neocortical borreliosis and Alzheimer's Disease. Ann N Y Acad Sci. 1988, 539: 468-470. 10.1111/j.1749-6632.1988.tb31909.x.
100.
go back to reference Meer-Scherrer L, Chang Loa C, Adelson ME, Mordechai E, Lobrinus JA, Fallon BA, Tilton RC: Lyme disease associated with Alzheimer's disease. Curr Microbiol. 2006, 52: 330-332. 10.1007/s00284-005-0454-7.PubMed Meer-Scherrer L, Chang Loa C, Adelson ME, Mordechai E, Lobrinus JA, Fallon BA, Tilton RC: Lyme disease associated with Alzheimer's disease. Curr Microbiol. 2006, 52: 330-332. 10.1007/s00284-005-0454-7.PubMed
101.
go back to reference MacDonald AB: Transfection ''Junk'' DNA - A link to the pathogenesis of Alzheimer's disease?. Med Hypotheses. 2006, 66: 1140-1141. 10.1016/j.mehy.2005.12.028.PubMed MacDonald AB: Transfection ''Junk'' DNA - A link to the pathogenesis of Alzheimer's disease?. Med Hypotheses. 2006, 66: 1140-1141. 10.1016/j.mehy.2005.12.028.PubMed
102.
go back to reference MacDonald AB: Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Med Hypotheses. 2006, 67: 592-600. 10.1016/j.mehy.2006.02.035.PubMed MacDonald AB: Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Med Hypotheses. 2006, 67: 592-600. 10.1016/j.mehy.2006.02.035.PubMed
103.
go back to reference Pappolla MA, Omar R, Saran B, Andorn A, Suarez M, Pavia C, Weinstein A, Shank D, Davis K, Burgdorfer W: Concurrent neuroborreliosis and Alzheimer's disease: analysis of the evidence. Hum Pathol. 1989, 20: 753-757. 10.1016/0046-8177(89)90068-3.PubMed Pappolla MA, Omar R, Saran B, Andorn A, Suarez M, Pavia C, Weinstein A, Shank D, Davis K, Burgdorfer W: Concurrent neuroborreliosis and Alzheimer's disease: analysis of the evidence. Hum Pathol. 1989, 20: 753-757. 10.1016/0046-8177(89)90068-3.PubMed
104.
go back to reference Gutacker M, Valsangiacomo C, Balmelli T, Bernasconi MV, Bouras C, Piffaretti JC: Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Res Microbiol. 1998, 149: 31-35. 10.1016/S0923-2508(97)83621-2.PubMed Gutacker M, Valsangiacomo C, Balmelli T, Bernasconi MV, Bouras C, Piffaretti JC: Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Res Microbiol. 1998, 149: 31-35. 10.1016/S0923-2508(97)83621-2.PubMed
105.
go back to reference Marques AR, Weir SC, Fahle GA, Fischer SH: Lack of evidence of Borrelia involvement in Alzheimer's disease. J Infect Dis. 2000, 182: 1006-1007. 10.1086/315792.PubMed Marques AR, Weir SC, Fahle GA, Fischer SH: Lack of evidence of Borrelia involvement in Alzheimer's disease. J Infect Dis. 2000, 182: 1006-1007. 10.1086/315792.PubMed
106.
go back to reference Galbussera A, Tremolizzo L, Isella V, Gelosa G, Vezzo R, Vigorè L, Brenna M, Ferrarese C, Appollonio I: Lack of evidence for Borrelia burgdorferi seropositivity in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008, 22: 308-10.1097/WAD.0b013e31816ba95d.PubMed Galbussera A, Tremolizzo L, Isella V, Gelosa G, Vezzo R, Vigorè L, Brenna M, Ferrarese C, Appollonio I: Lack of evidence for Borrelia burgdorferi seropositivity in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008, 22: 308-10.1097/WAD.0b013e31816ba95d.PubMed
107.
go back to reference Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K: Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006, 27: 228-236. 10.1016/j.neurobiolaging.2005.01.018.PubMed Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K: Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006, 27: 228-236. 10.1016/j.neurobiolaging.2005.01.018.PubMed
108.
go back to reference Nicolson GL: Chronic Bacterial and Viral Infections in Neurodegenerative and Neurobehavioral Diseases. Lab Med. 2008, 39: 291-299. 10.1309/96M3BWYP42L11BFU. Nicolson GL: Chronic Bacterial and Viral Infections in Neurodegenerative and Neurobehavioral Diseases. Lab Med. 2008, 39: 291-299. 10.1309/96M3BWYP42L11BFU.
109.
go back to reference Reiber H, Lange P: Quantification of Virus-Specific Antibodies in Cerebrospinal Fluid and Serum: Sensitive and Specific Detection of Antibody Synthesis in Brain. Clin Chem. 1991, 37: 1153-1160.PubMed Reiber H, Lange P: Quantification of Virus-Specific Antibodies in Cerebrospinal Fluid and Serum: Sensitive and Specific Detection of Antibody Synthesis in Brain. Clin Chem. 1991, 37: 1153-1160.PubMed
110.
go back to reference Furuta Y, Kawabata H, Ohtani F, Watanabe H: Western blot analysis for diagnosis of Lyme disease in acute facial palsy. Laryngoscope. 2001, 111: 719-723. 10.1097/00005537-200104000-00028.PubMed Furuta Y, Kawabata H, Ohtani F, Watanabe H: Western blot analysis for diagnosis of Lyme disease in acute facial palsy. Laryngoscope. 2001, 111: 719-723. 10.1097/00005537-200104000-00028.PubMed
111.
go back to reference Gylfe A, Wahlgren M, Fahlén L, Bergström S: Activation of latent Lyme borreliosis concurrent with a herpes simplex virus type 1 infection. Scand J Infect Dis. 2002, 34: 922-924. 10.1080/0036554021000026972.PubMed Gylfe A, Wahlgren M, Fahlén L, Bergström S: Activation of latent Lyme borreliosis concurrent with a herpes simplex virus type 1 infection. Scand J Infect Dis. 2002, 34: 922-924. 10.1080/0036554021000026972.PubMed
112.
go back to reference Mantovani E, Costa IP, Gauditano G, Bonoldi VL, Higuchi ML, Yoshinari NH: Description of Lyme disease-like syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation? Braz J Med Biol Res. 2007, 40: 443-456.PubMed Mantovani E, Costa IP, Gauditano G, Bonoldi VL, Higuchi ML, Yoshinari NH: Description of Lyme disease-like syndrome in Brazil. Is it a new tick borne disease or Lyme disease variation? Braz J Med Biol Res. 2007, 40: 443-456.PubMed
113.
go back to reference Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol. 1998, 187: 23-42. 10.1007/s004300050071.PubMed Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol. 1998, 187: 23-42. 10.1007/s004300050071.PubMed
114.
go back to reference Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gérard HC, Hudson AP: Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis. 2008, 13: 371-380.PubMed Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gérard HC, Hudson AP: Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis. 2008, 13: 371-380.PubMed
115.
go back to reference Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF: Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol. 1991, 33: 224-227. 10.1002/jmv.1890330403.PubMed Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF: Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol. 1991, 33: 224-227. 10.1002/jmv.1890330403.PubMed
116.
go back to reference Itzhaki RF, Wozniak MA: Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis. 2008, 13: 393-405.PubMed Itzhaki RF, Wozniak MA: Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis. 2008, 13: 393-405.PubMed
117.
go back to reference Martîn-de-Argila C, Boixeda D, Cantón R, Gisbert JP, Fuertes A: High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet. 1995, 346: 310.PubMed Martîn-de-Argila C, Boixeda D, Cantón R, Gisbert JP, Fuertes A: High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet. 1995, 346: 310.PubMed
118.
go back to reference Yoon JW, Jun HS: Viruses cause type 1 diabetes in animals. Ann NY Acad Sci. 2006, 1079: 138-146. 10.1196/annals.1375.021.PubMed Yoon JW, Jun HS: Viruses cause type 1 diabetes in animals. Ann NY Acad Sci. 2006, 1079: 138-146. 10.1196/annals.1375.021.PubMed
119.
go back to reference Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ: Helicobacter pylori infection and endocrine disorders: is there a link?. World J Gastroenterol. 2009, 15: 2701-2707. 10.3748/wjg.15.2701.PubMedCentralPubMed Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ: Helicobacter pylori infection and endocrine disorders: is there a link?. World J Gastroenterol. 2009, 15: 2701-2707. 10.3748/wjg.15.2701.PubMedCentralPubMed
120.
go back to reference Inaba H, Amano A: Roles of Oral Bacteria in Cardiovascular Diseases - From Molecular Mechanisms to Clinical Cases: Implication of Periodontal Diseases in Development of Systemic Diseases. J Pharmacol Sci. 2010, 113: 103-109. 10.1254/jphs.09R23FM.PubMed Inaba H, Amano A: Roles of Oral Bacteria in Cardiovascular Diseases - From Molecular Mechanisms to Clinical Cases: Implication of Periodontal Diseases in Development of Systemic Diseases. J Pharmacol Sci. 2010, 113: 103-109. 10.1254/jphs.09R23FM.PubMed
121.
go back to reference Kamer AR, Craig RG, Dasanayake AP, Brys M, Glodzik-Sobanska L, de Leon MJ: Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement. 2008, 4: 242-250. 10.1016/j.jalz.2007.08.004.PubMed Kamer AR, Craig RG, Dasanayake AP, Brys M, Glodzik-Sobanska L, de Leon MJ: Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement. 2008, 4: 242-250. 10.1016/j.jalz.2007.08.004.PubMed
122.
go back to reference Averback P: Two new lesions in Alzheimer's disease. Lancet. 1983, 2: 1203.PubMed Averback P: Two new lesions in Alzheimer's disease. Lancet. 1983, 2: 1203.PubMed
123.
go back to reference Mann DM, Tucker CM, Yates PO: Alzheimer's disease: an olfactory connection?. Mech Aging Develop. 1988, 42: 1-15. 10.1016/0047-6374(88)90058-9. Mann DM, Tucker CM, Yates PO: Alzheimer's disease: an olfactory connection?. Mech Aging Develop. 1988, 42: 1-15. 10.1016/0047-6374(88)90058-9.
124.
go back to reference Hardy JA, Mann DM, Wester P, Winblad B: An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging. 1986, 7: 489-502. 10.1016/0197-4580(86)90086-2.PubMed Hardy JA, Mann DM, Wester P, Winblad B: An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging. 1986, 7: 489-502. 10.1016/0197-4580(86)90086-2.PubMed
125.
go back to reference Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J: Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci. 2003, 30: 20-25.PubMed Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J: Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci. 2003, 30: 20-25.PubMed
126.
go back to reference Umemoto T, Li M, Namikawa I: Adherence of human oral spirochetes by collagen-binding proteins. Microbiol Immunol. 1997, 41: 917-923.PubMed Umemoto T, Li M, Namikawa I: Adherence of human oral spirochetes by collagen-binding proteins. Microbiol Immunol. 1997, 41: 917-923.PubMed
127.
go back to reference Skare JT, Mirzabekov TA, Shang ES, Blanco DR, Erdjument-Bromage H, Bunikis J, Bergström S, Tempst P, Kagan BL, Miller JN, Lovett MA: The Oms66 (p66) protein is a Borrelia burgdorferi porin. Infect Immun. 1997, 65: 3654-3661.PubMedCentralPubMed Skare JT, Mirzabekov TA, Shang ES, Blanco DR, Erdjument-Bromage H, Bunikis J, Bergström S, Tempst P, Kagan BL, Miller JN, Lovett MA: The Oms66 (p66) protein is a Borrelia burgdorferi porin. Infect Immun. 1997, 65: 3654-3661.PubMedCentralPubMed
128.
go back to reference Cluss RG, Silverman DA, Stafford TR: Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein. Infect Immun. 2004, 72: 6279-6286. 10.1128/IAI.72.11.6279-6286.2004.PubMedCentralPubMed Cluss RG, Silverman DA, Stafford TR: Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein. Infect Immun. 2004, 72: 6279-6286. 10.1128/IAI.72.11.6279-6286.2004.PubMedCentralPubMed
129.
go back to reference Bárcena-Uribarri I, Thein M, Sacher A, Bunikis I, Bonde M, Bergström S, Benz R: P66 porins are present in both Lyme disease and relapsing fever spirochetes: a comparison of the biophysical properties of P66 porins from six Borrelia species. Biochim Biophys Acta. 2010, 1798: 1197-1203. 10.1016/j.bbamem.2010.02.011.PubMed Bárcena-Uribarri I, Thein M, Sacher A, Bunikis I, Bonde M, Bergström S, Benz R: P66 porins are present in both Lyme disease and relapsing fever spirochetes: a comparison of the biophysical properties of P66 porins from six Borrelia species. Biochim Biophys Acta. 2010, 1798: 1197-1203. 10.1016/j.bbamem.2010.02.011.PubMed
130.
go back to reference Brissette CA, Rossmann E, Bowman A, Cooley AE, Riley SP, Hunfeld KP, Bechtel M, Kraiczy P, Stevenson B: The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease. Clin Vaccine Immunol. 2010, 17: 274-280. 10.1128/CVI.00437-09.PubMedCentralPubMed Brissette CA, Rossmann E, Bowman A, Cooley AE, Riley SP, Hunfeld KP, Bechtel M, Kraiczy P, Stevenson B: The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease. Clin Vaccine Immunol. 2010, 17: 274-280. 10.1128/CVI.00437-09.PubMedCentralPubMed
131.
go back to reference Coburn J, Cugini C: Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3. Proc Natl Acad Sci USA. 2003, 100: 7301-7306. 10.1073/pnas.1131117100.PubMedCentralPubMed Coburn J, Cugini C: Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3. Proc Natl Acad Sci USA. 2003, 100: 7301-7306. 10.1073/pnas.1131117100.PubMedCentralPubMed
132.
go back to reference Gebbink MF, Claessen D, Bouma B, Dijkhuizen L, Wösten HA: Amyloids-a functional coat for microorganisms. Nat Rev Microbiol. 2005, 3: 333-341. 10.1038/nrmicro1127.PubMed Gebbink MF, Claessen D, Bouma B, Dijkhuizen L, Wösten HA: Amyloids-a functional coat for microorganisms. Nat Rev Microbiol. 2005, 3: 333-341. 10.1038/nrmicro1127.PubMed
133.
go back to reference Crack PJ, Bray PJ: Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol. 2007, 85: 476-480. 10.1038/sj.icb.7100103.PubMed Crack PJ, Bray PJ: Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol. 2007, 85: 476-480. 10.1038/sj.icb.7100103.PubMed
134.
go back to reference Bulut Y, Faure E, Thomas L, Equils O, Arditi M: Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol. 2001, 167: 987-994.PubMed Bulut Y, Faure E, Thomas L, Equils O, Arditi M: Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol. 2001, 167: 987-994.PubMed
135.
go back to reference Sellati TJ, Bouis DA, Kitchens RL, Darveau RP, Pugin J, Ulevitch RJ, Gangloff SC, Goyert SM, Norgard MV, Radolf JD: Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol. 1998, 160: 5455-5464.PubMed Sellati TJ, Bouis DA, Kitchens RL, Darveau RP, Pugin J, Ulevitch RJ, Gangloff SC, Goyert SM, Norgard MV, Radolf JD: Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol. 1998, 160: 5455-5464.PubMed
136.
go back to reference Schröder NW, Heine H, Alexander C, Manukyan M, Eckert J, Hamann L, Göbel UB, Schumann RR: Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol. 2004, 173: 2683-2691.PubMed Schröder NW, Heine H, Alexander C, Manukyan M, Eckert J, Hamann L, Göbel UB, Schumann RR: Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol. 2004, 173: 2683-2691.PubMed
137.
go back to reference Fisher GH, D'Aniello A, Vetere A, Padula L, Cusano GP, Man EH: Free D-aspartate and D-alanine in normal and Alzheimer brain. Brain Res Bull. 1991, 26: 983-985. 10.1016/0361-9230(91)90266-M.PubMed Fisher GH, D'Aniello A, Vetere A, Padula L, Cusano GP, Man EH: Free D-aspartate and D-alanine in normal and Alzheimer brain. Brain Res Bull. 1991, 26: 983-985. 10.1016/0361-9230(91)90266-M.PubMed
138.
go back to reference D'Aniello A, Vetere A, Fisher GH, Cusano G, Chavez M, Petrucelli L: Presence of D-alanine in proteins of normal and Alzheimer human brain. Brain Res. 1992, 592: 44-48. 10.1016/0006-8993(92)91656-Y.PubMed D'Aniello A, Vetere A, Fisher GH, Cusano G, Chavez M, Petrucelli L: Presence of D-alanine in proteins of normal and Alzheimer human brain. Brain Res. 1992, 592: 44-48. 10.1016/0006-8993(92)91656-Y.PubMed
139.
go back to reference Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E, Reino M, Geroldi D: Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett. 2006, 391: 147-149. 10.1016/j.neulet.2005.08.047.PubMed Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E, Reino M, Geroldi D: Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett. 2006, 391: 147-149. 10.1016/j.neulet.2005.08.047.PubMed
140.
go back to reference Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, Listì F, Vasto S, Lio D, Caruso C, Candore G: Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr Pharm Des. 2008, 14: 2672-2677. 10.2174/138161208786264089.PubMed Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, Listì F, Vasto S, Lio D, Caruso C, Candore G: Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr Pharm Des. 2008, 14: 2672-2677. 10.2174/138161208786264089.PubMed
141.
go back to reference Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K: Role of toll-like receptor signalling in Abeta uptake and clearance. Brain. 2006, 129: 3006-3019. 10.1093/brain/awl249.PubMedCentralPubMed Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K: Role of toll-like receptor signalling in Abeta uptake and clearance. Brain. 2006, 129: 3006-3019. 10.1093/brain/awl249.PubMedCentralPubMed
142.
go back to reference Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T: Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J Neurosci. 2009, 29: 1846-1854. 10.1523/JNEUROSCI.5715-08.2009.PubMedCentralPubMed Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T: Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J Neurosci. 2009, 29: 1846-1854. 10.1523/JNEUROSCI.5715-08.2009.PubMedCentralPubMed
143.
go back to reference Blanco DR, Champion CI, Lewinski MA, Shang ES, Simkins SG, Miller JN, Lovett MA: Immunization with Treponema pallidum outer membrane vesicles induces high-titer complement-dependent treponemicidal activity and aggregation of T. pallidum rare outer membrane proteins (TROMPs). J Immunol. 1999, 163: 2741-2746.PubMed Blanco DR, Champion CI, Lewinski MA, Shang ES, Simkins SG, Miller JN, Lovett MA: Immunization with Treponema pallidum outer membrane vesicles induces high-titer complement-dependent treponemicidal activity and aggregation of T. pallidum rare outer membrane proteins (TROMPs). J Immunol. 1999, 163: 2741-2746.PubMed
144.
go back to reference Lawrenz MB, Wooten RM, Zachary JF, Drouin SM, Weis JJ, Wetsel RA, Norris SJ: Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun. 2003, 71: 4432-4440. 10.1128/IAI.71.8.4432-4440.2003.PubMedCentralPubMed Lawrenz MB, Wooten RM, Zachary JF, Drouin SM, Weis JJ, Wetsel RA, Norris SJ: Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun. 2003, 71: 4432-4440. 10.1128/IAI.71.8.4432-4440.2003.PubMedCentralPubMed
145.
go back to reference Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V: Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol. 2001, 1: 393-401. 10.1016/S1567-5769(00)00041-2.PubMed Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V: Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol. 2001, 1: 393-401. 10.1016/S1567-5769(00)00041-2.PubMed
146.
go back to reference Ray A, Kumar D, Shakya A, Brown CR, Cook JL, Ray BK: Serum amyloid A-activating factor-1 (SAF-1) transgenic mice are prone to develop a severe form of inflammation-induced arthritis. J Immunol. 2004, 173: 4684-4691.PubMed Ray A, Kumar D, Shakya A, Brown CR, Cook JL, Ray BK: Serum amyloid A-activating factor-1 (SAF-1) transgenic mice are prone to develop a severe form of inflammation-induced arthritis. J Immunol. 2004, 173: 4684-4691.PubMed
147.
go back to reference Berlit P: Clinical and laboratory findings with giant cell arteritis. J Neurol Sci. 1992, 111: 1-12. 10.1016/0022-510X(92)90105-T.PubMed Berlit P: Clinical and laboratory findings with giant cell arteritis. J Neurol Sci. 1992, 111: 1-12. 10.1016/0022-510X(92)90105-T.PubMed
148.
go back to reference Marangoni A, Aldini R, Sambri V, Giacani L, Di Leo K, Cevenini R: Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunol Med Microbiol. 2004, 40: 187-191. 10.1016/S0928-8244(03)00345-6.PubMed Marangoni A, Aldini R, Sambri V, Giacani L, Di Leo K, Cevenini R: Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunol Med Microbiol. 2004, 40: 187-191. 10.1016/S0928-8244(03)00345-6.PubMed
149.
go back to reference McGeer PL, McGeer E, Rogers J, Sibley J: Anti-inflammatory drugs and Alzheimer disease. Lancet. 1990, 335: 1037.PubMed McGeer PL, McGeer E, Rogers J, Sibley J: Anti-inflammatory drugs and Alzheimer disease. Lancet. 1990, 335: 1037.PubMed
150.
go back to reference Kraiczy P, Würzner R: Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol. 2006, 43: 31-44. 10.1016/j.molimm.2005.06.016.PubMed Kraiczy P, Würzner R: Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol. 2006, 43: 31-44. 10.1016/j.molimm.2005.06.016.PubMed
151.
go back to reference Pausa M, Pellis V, Cinco M, Giulianini PG, Presani G, Perticarari S, Murgia R, Tedesco F: Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J Immunol. 2003, 170: 3214-3222.PubMed Pausa M, Pellis V, Cinco M, Giulianini PG, Presani G, Perticarari S, Murgia R, Tedesco F: Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J Immunol. 2003, 170: 3214-3222.PubMed
152.
go back to reference Radolf JD, Robinson EJ, Bourell KW, Akins DR, Porcella SF, Weigel LM, Jones JD, Norgard MV: Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease spirochete. Infect Immun. 1995, 63: 2154-2163.PubMedCentralPubMed Radolf JD, Robinson EJ, Bourell KW, Akins DR, Porcella SF, Weigel LM, Jones JD, Norgard MV: Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease spirochete. Infect Immun. 1995, 63: 2154-2163.PubMedCentralPubMed
153.
go back to reference Rasley A, Anguita J, Marriott I: Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol. 2002, 130: 22-31. 10.1016/S0165-5728(02)00187-X.PubMed Rasley A, Anguita J, Marriott I: Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol. 2002, 130: 22-31. 10.1016/S0165-5728(02)00187-X.PubMed
154.
go back to reference Ramesh G, Alvarez AL, Roberts ED, Dennis VA, Lasater BL, Alvarez X, Philipp MT: Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol. 2003, 33: 2539-2550. 10.1002/eji.200323872.PubMed Ramesh G, Alvarez AL, Roberts ED, Dennis VA, Lasater BL, Alvarez X, Philipp MT: Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol. 2003, 33: 2539-2550. 10.1002/eji.200323872.PubMed
155.
go back to reference Weinberg G, Miklossy J: Iron and infection. J Alzheimer's Dis. 2008, 13: 451-463. Weinberg G, Miklossy J: Iron and infection. J Alzheimer's Dis. 2008, 13: 451-463.
156.
go back to reference Griffiths E: Iron and bacterial virulence - a brief overview. Biol Met. 1991, 4: 7-13. 10.1007/BF01135551.PubMed Griffiths E: Iron and bacterial virulence - a brief overview. Biol Met. 1991, 4: 7-13. 10.1007/BF01135551.PubMed
157.
go back to reference Weinberg ED: Iron depletion: a defense against intracellular infection and neoplasia. Life Sci. 1992, 50: 1289-1297. 10.1016/0024-3205(92)90279-X.PubMed Weinberg ED: Iron depletion: a defense against intracellular infection and neoplasia. Life Sci. 1992, 50: 1289-1297. 10.1016/0024-3205(92)90279-X.PubMed
158.
go back to reference Goodman L: Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis. 1953, 118: 97-130. 10.1097/00005053-195308000-00001.PubMed Goodman L: Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis. 1953, 118: 97-130. 10.1097/00005053-195308000-00001.PubMed
159.
go back to reference Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA: Iron: a pathological mediator of Alzheimer disease?. Dev Neurosci. 2002, 24: 184-187. 10.1159/000065696.PubMed Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA: Iron: a pathological mediator of Alzheimer disease?. Dev Neurosci. 2002, 24: 184-187. 10.1159/000065696.PubMed
160.
go back to reference Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J: Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol. 2006, 155: 30-37. 10.1016/j.jsb.2005.09.004.PubMed Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J: Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol. 2006, 155: 30-37. 10.1016/j.jsb.2005.09.004.PubMed
161.
go back to reference Lirk P, Hoffmann G, Rieder J: Inducible nitric oxide synthase--time for reappraisal. Curr Drug Targets Inflamm Allergy. 2002, 1: 89-108. 10.2174/1568010023344913.PubMed Lirk P, Hoffmann G, Rieder J: Inducible nitric oxide synthase--time for reappraisal. Curr Drug Targets Inflamm Allergy. 2002, 1: 89-108. 10.2174/1568010023344913.PubMed
162.
go back to reference Bogdan C: Nitric oxide and the immune response. Nat Immunol. 2001, 2: 907-916.PubMed Bogdan C: Nitric oxide and the immune response. Nat Immunol. 2001, 2: 907-916.PubMed
163.
go back to reference Ohnishi S, Koide A, Koide SJ: Solution conformation and amyloid-like fibril formation of a polar peptide derived from a b-hairpin in the OspA single-layer b-sheet. Mol Biol. 2000, 301: 477-489. 10.1006/jmbi.2000.3980. Ohnishi S, Koide A, Koide SJ: Solution conformation and amyloid-like fibril formation of a polar peptide derived from a b-hairpin in the OspA single-layer b-sheet. Mol Biol. 2000, 301: 477-489. 10.1006/jmbi.2000.3980.
164.
go back to reference Ohnishi S, Koide A, Koide S: The roles of turn formation and cross-strand interactions in fibrillization of peptides derived from the OspA single-layer beta-sheet. Protein Sci. 2001, 10: 2083-2092. 10.1110/ps.15901.PubMedCentralPubMed Ohnishi S, Koide A, Koide S: The roles of turn formation and cross-strand interactions in fibrillization of peptides derived from the OspA single-layer beta-sheet. Protein Sci. 2001, 10: 2083-2092. 10.1110/ps.15901.PubMedCentralPubMed
165.
go back to reference Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hultgren SJ: : Role of Escherichia coli curli operons in directing amyloid fiber formation. Science. 2002, 295: 851-855. 10.1126/science.1067484.PubMedCentralPubMed Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hultgren SJ: : Role of Escherichia coli curli operons in directing amyloid fiber formation. Science. 2002, 295: 851-855. 10.1126/science.1067484.PubMedCentralPubMed
166.
go back to reference Otzen D, Nielsen PH: We find them here, we find them there: functional bacterial amyloid. Cell Mol Life Sci. 2008, 65: 910-927. 10.1007/s00018-007-7404-4.PubMed Otzen D, Nielsen PH: We find them here, we find them there: functional bacterial amyloid. Cell Mol Life Sci. 2008, 65: 910-927. 10.1007/s00018-007-7404-4.PubMed
167.
go back to reference Larsen P, Nielsen JL, Dueholm MS, Wetzel R, Otzen D, Nielsen PH: Amyloid adhesins are abundant in natural biofilms. Environ Microbiol. 2007, 9: 3077-3090. 10.1111/j.1462-2920.2007.01418.x.PubMed Larsen P, Nielsen JL, Dueholm MS, Wetzel R, Otzen D, Nielsen PH: Amyloid adhesins are abundant in natural biofilms. Environ Microbiol. 2007, 9: 3077-3090. 10.1111/j.1462-2920.2007.01418.x.PubMed
168.
go back to reference Jordal PB, Dueholm MS, Larsen P, Petersen SV, Enghild JJ, Christiansen G, Højrup P, Nielsen PH, Otzen DE: Widespread abundance of functional bacterial amyloid in Mycolata and other Gram-positive bacteria. Appl Environ Microbiol. 2009, 75: 4101-4110. 10.1128/AEM.02107-08.PubMedCentralPubMed Jordal PB, Dueholm MS, Larsen P, Petersen SV, Enghild JJ, Christiansen G, Højrup P, Nielsen PH, Otzen DE: Widespread abundance of functional bacterial amyloid in Mycolata and other Gram-positive bacteria. Appl Environ Microbiol. 2009, 75: 4101-4110. 10.1128/AEM.02107-08.PubMedCentralPubMed
169.
go back to reference Hardy J: The Alzheimer family of diseases: many etiologies, one pathogenesis?. Proc Natl Acad Sci USA. 1997, 94: 2095-2097. 10.1073/pnas.94.6.2095.PubMedCentralPubMed Hardy J: The Alzheimer family of diseases: many etiologies, one pathogenesis?. Proc Natl Acad Sci USA. 1997, 94: 2095-2097. 10.1073/pnas.94.6.2095.PubMedCentralPubMed
170.
go back to reference Schubert D, Schroeder R, LaCorbiere M, Saitoh T, Cole G: Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. Science. 1998, 241: 1759-1763. Schubert D, Schroeder R, LaCorbiere M, Saitoh T, Cole G: Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. Science. 1998, 241: 1759-1763.
171.
go back to reference Allen JS, Murphy GM, Eng LF, Stultz KE, Davies HD, Pickford LB, Tinklenberg JR: Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells. Neurosci Lett. 1991, 132: 109-112. 10.1016/0304-3940(91)90445-Y.PubMed Allen JS, Murphy GM, Eng LF, Stultz KE, Davies HD, Pickford LB, Tinklenberg JR: Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells. Neurosci Lett. 1991, 132: 109-112. 10.1016/0304-3940(91)90445-Y.PubMed
172.
go back to reference Mönning U, König G, Prior R, Mechler H, Schreiter-Gasser U, Masters CL, Beyreuther K: Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Lett. 1990, 277: 261-266. 10.1016/0014-5793(90)80861-C.PubMed Mönning U, König G, Prior R, Mechler H, Schreiter-Gasser U, Masters CL, Beyreuther K: Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Lett. 1990, 277: 261-266. 10.1016/0014-5793(90)80861-C.PubMed
173.
go back to reference Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, Cashman NR: Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol. 1993, 150: 5566-5575.PubMed Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, Cashman NR: Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol. 1993, 150: 5566-5575.PubMed
174.
go back to reference Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD: The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010, 5: e9505-10.1371/journal.pone.0009505.PubMedCentralPubMed Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD: The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One. 2010, 5: e9505-10.1371/journal.pone.0009505.PubMedCentralPubMed
175.
go back to reference Urosevic N, Martins RN: Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis. 2008, 13: 421-435.PubMed Urosevic N, Martins RN: Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis. 2008, 13: 421-435.PubMed
176.
go back to reference Licastro F, Porcellini E, Caruso C, Lio D, Corder EH: Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging. 2007, 28: 1637-1643. 10.1016/j.neurobiolaging.2006.07.007.PubMed Licastro F, Porcellini E, Caruso C, Lio D, Corder EH: Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging. 2007, 28: 1637-1643. 10.1016/j.neurobiolaging.2006.07.007.PubMed
177.
go back to reference Knight JC, Kwiatkowski D: Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians. 1999, 111: 290-298. 10.1046/j.1525-1381.1999.99237.x.PubMed Knight JC, Kwiatkowski D: Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians. 1999, 111: 290-298. 10.1046/j.1525-1381.1999.99237.x.PubMed
178.
go back to reference Shaw MA, Donaldson IJ, Collins A, Peacock CS, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM: Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun. 2001, 2: 196-204. 10.1038/sj.gene.6363754.PubMed Shaw MA, Donaldson IJ, Collins A, Peacock CS, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM: Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun. 2001, 2: 196-204. 10.1038/sj.gene.6363754.PubMed
179.
go back to reference Sigal LH: Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol. 1997, 15: 63-92. 10.1146/annurev.immunol.15.1.63.PubMed Sigal LH: Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol. 1997, 15: 63-92. 10.1146/annurev.immunol.15.1.63.PubMed
180.
go back to reference Marangoni A, Aldini R, Sambri V, Giacani L, Di Leo K, Cevenini R: Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunol Med Microbiol. 2004, 40: 187-191. 10.1016/S0928-8244(03)00345-6.PubMed Marangoni A, Aldini R, Sambri V, Giacani L, Di Leo K, Cevenini R: Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunol Med Microbiol. 2004, 40: 187-191. 10.1016/S0928-8244(03)00345-6.PubMed
181.
go back to reference Steere AC, Dwyer E, Winchester R: Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990, 323: 219-223. 10.1056/NEJM199007263230402.PubMed Steere AC, Dwyer E, Winchester R: Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990, 323: 219-223. 10.1056/NEJM199007263230402.PubMed
182.
go back to reference Collins JS, Perry RT, Watson B, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Campbell RD, Go RC: Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet. 2000, 96: 823-830. 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I.PubMed Collins JS, Perry RT, Watson B, Harrell LE, Acton RT, Blacker D, Albert MS, Tanzi RE, Bassett SS, McInnis MG, Campbell RD, Go RC: Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet. 2000, 96: 823-830. 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I.PubMed
183.
go back to reference McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 2001, 357: 436-439. 10.1016/S0140-6736(00)04008-3.PubMed McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP: Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 2001, 357: 436-439. 10.1016/S0140-6736(00)04008-3.PubMed
184.
go back to reference Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN: Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation. 2008, 5: 36-10.1186/1742-2094-5-36.PubMedCentralPubMed Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN: Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation. 2008, 5: 36-10.1186/1742-2094-5-36.PubMedCentralPubMed
185.
go back to reference Honjo K, van Reekum R, Verhoeff NP: Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?. Alzheimers Dement. 2009, 5: 348-360. 10.1016/j.jalz.2008.12.001.PubMed Honjo K, van Reekum R, Verhoeff NP: Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?. Alzheimers Dement. 2009, 5: 348-360. 10.1016/j.jalz.2008.12.001.PubMed
186.
go back to reference Wisniewsky HM: Possible viral etiology of neurofibrillary changes and neuritic plaques. Alzheimer's Disease: Senile Dementia and Related Disorders (Aging, Vol 7). Edited by: Katzman R, Terry RD, Bick KL. 1978, Raven Press, New York, NA, 555-557. Wisniewsky HM: Possible viral etiology of neurofibrillary changes and neuritic plaques. Alzheimer's Disease: Senile Dementia and Related Disorders (Aging, Vol 7). Edited by: Katzman R, Terry RD, Bick KL. 1978, Raven Press, New York, NA, 555-557.
187.
go back to reference Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol. 1985, 42: 1097-1105.PubMed Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol. 1985, 42: 1097-1105.PubMed
188.
go back to reference Rosenbaum M, Roseman E, Aring CD, Ferris EB: Intracranial blood flow in dementia paralytica, cerebral atrophy and schizophrenia. Arch Neurol Psychiat. 1942, 47: 793. Rosenbaum M, Roseman E, Aring CD, Ferris EB: Intracranial blood flow in dementia paralytica, cerebral atrophy and schizophrenia. Arch Neurol Psychiat. 1942, 47: 793.
189.
go back to reference Sumiya H, Kobayashi K, Mizukoshi C, Aoki T, Koshino Y, Taki J, Tonami N: Brain perfusion SPECT in Lyme neuroborreliosis.?. J Nucl Med. 1997, 38: 1120-1122.PubMed Sumiya H, Kobayashi K, Mizukoshi C, Aoki T, Koshino Y, Taki J, Tonami N: Brain perfusion SPECT in Lyme neuroborreliosis.?. J Nucl Med. 1997, 38: 1120-1122.PubMed
190.
go back to reference Logigian EL, Johnson KA, Kijewski MF, Kaplan RF, Becker JA, Jones KJ, Garada BM, Holman BL, Steere AC: Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology. 1997, 49: 1661-1670.PubMed Logigian EL, Johnson KA, Kijewski MF, Kaplan RF, Becker JA, Jones KJ, Garada BM, Holman BL, Steere AC: Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology. 1997, 49: 1661-1670.PubMed
191.
go back to reference Patterson JL, Heyman A, Nichols FT: Cerebral blood flow and oxygen consumption in neurosyphilis. J Clin Invest. 1950, 10: 1327-1334. Patterson JL, Heyman A, Nichols FT: Cerebral blood flow and oxygen consumption in neurosyphilis. J Clin Invest. 1950, 10: 1327-1334.
192.
go back to reference Miklossy J, Kuntzer T, Bogousslavsky J, Regli F, Janzer RC: Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol. 1990, 80: 568-572. 10.1007/BF00294622.PubMed Miklossy J, Kuntzer T, Bogousslavsky J, Regli F, Janzer RC: Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol. 1990, 80: 568-572. 10.1007/BF00294622.PubMed
193.
go back to reference Hachinski V, Munoz DG: Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?. Ann N Y Acad Sci. 1997, 26: 1-6. Hachinski V, Munoz DG: Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?. Ann N Y Acad Sci. 1997, 26: 1-6.
194.
go back to reference Johnson K, Mueller S, Walshe T, English R, Holman B: Cerebral perfusion imaging in Alzheimer's disease. Arch Neurol. 1987, 44: 165-168.PubMed Johnson K, Mueller S, Walshe T, English R, Holman B: Cerebral perfusion imaging in Alzheimer's disease. Arch Neurol. 1987, 44: 165-168.PubMed
195.
go back to reference de la Torre JC: Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci. 2000, 924: 136-152.PubMed de la Torre JC: Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci. 2000, 924: 136-152.PubMed
196.
go back to reference Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD: Cerebrovascular disease and threshold for dementia in the early stage of Alzheimer's disease. Lancet. 1999, 354: 919-920. 10.1016/S0140-6736(99)02355-7.PubMed Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD: Cerebrovascular disease and threshold for dementia in the early stage of Alzheimer's disease. Lancet. 1999, 354: 919-920. 10.1016/S0140-6736(99)02355-7.PubMed
197.
go back to reference Kalaria RN: The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000, 21: 321-330. 10.1016/S0197-4580(00)00125-1.PubMed Kalaria RN: The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000, 21: 321-330. 10.1016/S0197-4580(00)00125-1.PubMed
198.
go back to reference Miklossy J: Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res. 2003, 25: 605-610. 10.1179/016164103101202048.PubMed Miklossy J: Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res. 2003, 25: 605-610. 10.1179/016164103101202048.PubMed
199.
go back to reference Suter OC, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J: Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke. 2002, 33: 1986-1992. 10.1161/01.STR.0000024523.82311.77.PubMed Suter OC, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J: Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke. 2002, 33: 1986-1992. 10.1161/01.STR.0000024523.82311.77.PubMed
200.
go back to reference Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ: Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol. 1993, 74: 441-454.PubMedCentralPubMed Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ: Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol. 1993, 74: 441-454.PubMedCentralPubMed
201.
go back to reference Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ: Experimental induction of beta-amyloid plaques and cerebral angiopathy in primates. Ann N Y Acad Sci. 1993, 695: 228-231. 10.1111/j.1749-6632.1993.tb23057.x.PubMed Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ: Experimental induction of beta-amyloid plaques and cerebral angiopathy in primates. Ann N Y Acad Sci. 1993, 695: 228-231. 10.1111/j.1749-6632.1993.tb23057.x.PubMed
202.
go back to reference Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ: Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol. 1994, 8: 25-39. 10.1007/BF02778005.PubMed Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ: Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol. 1994, 8: 25-39. 10.1007/BF02778005.PubMed
203.
go back to reference Ridley RM, Baker HF, Windle CP, Cummings RM: Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm. 2006, 113: 1243-1251. 10.1007/s00702-005-0385-2.PubMed Ridley RM, Baker HF, Windle CP, Cummings RM: Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm. 2006, 113: 1243-1251. 10.1007/s00702-005-0385-2.PubMed
204.
go back to reference Kornhuber HH: Propionibacterium acnes in the cortex of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1996, 246: 108-109. 10.1007/BF02274902.PubMed Kornhuber HH: Propionibacterium acnes in the cortex of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1996, 246: 108-109. 10.1007/BF02274902.PubMed
205.
go back to reference Kornhuber HH: Reply on critical comments on Propionibacterium acnes in the cortex of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1996, 246: 226. Kornhuber HH: Reply on critical comments on Propionibacterium acnes in the cortex of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 1996, 246: 226.
206.
go back to reference Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, Smith S, Borrie M, Decoteau E, Davidson W, McDougall A, Gnarpe J, O'DONNell M, Chernesky M: A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J Am Geriatr Soc. 2004, 52: 381-387. 10.1111/j.1532-5415.2004.52109.x.PubMed Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, Smith S, Borrie M, Decoteau E, Davidson W, McDougall A, Gnarpe J, O'DONNell M, Chernesky M: A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J Am Geriatr Soc. 2004, 52: 381-387. 10.1111/j.1532-5415.2004.52109.x.PubMed
207.
go back to reference Tsai GE, Falk WE, Gunther J, Coyle JT: Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry. 1999, 156: 467-469.PubMed Tsai GE, Falk WE, Gunther J, Coyle JT: Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry. 1999, 156: 467-469.PubMed
208.
go back to reference Kim HS, Suh YH: Minocycline and neurodegenerative diseases. Behav Brain Res. 2009, 196: 168-179. 10.1016/j.bbr.2008.09.040.PubMed Kim HS, Suh YH: Minocycline and neurodegenerative diseases. Behav Brain Res. 2009, 196: 168-179. 10.1016/j.bbr.2008.09.040.PubMed
Metadata
Title
Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria
Author
Judith Miklossy
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-8-90

Other articles of this Issue 1/2011

Journal of Neuroinflammation 1/2011 Go to the issue